FDA touts number of drugs approved in FY 2011
Almost half of the drugs were judged to be significant therapeutic advances over existing therapies for myocardial infarction, stroke and kidney transplant rejection. • Ten are for rare or "orphan" diseases, which frequently lack any therapy because of ...
FDA approvals of innovative drugs up for FY2011
FDA Drug Approvals Having A Good Run